4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000899243-20-007219
Options or other derivatives
- Pres., R&D, and CMO acquired 44,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Taub Rebecca Pres., R&D, and CMO | 2020-03-05 | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | D | ||
Loading xslF345X03/doc4.xml…